AGENDA

DAY 1

Wednesday, 25 September 2024

09h00

Welcome coffee and registration

09h50

Welcome address

10h00

Opening Keynote Lecture

- Descartes Auditorium

Chairman

10h00

Title to be announced

Cécile GENY

Head of MSAT Global Vaccine

Sanofi, France

10h30

Breakthrough Innovations in Bioproduction - Session I

- Descartes Auditorium

Chairman

10h30

Title to be announced

Anabelle PERRIER

Market Research Manager

MabDesign, France

10h40

Title to be announced

Michael SAINT-GUILLAIN

CEO & Co-Founder

Rombio, Belgium

10h50

Title to be announced

Daniel ORTMANN

Scientific Co-Founder

Plurify, United Kingdom

11h00

Title to be announced

Alexis DELBAERE

CEO

Cell-Easy, France

11h10

Cell●Secret●Service Platform Transforms Secretomes from Resolution-Associated Macrophages into Biological Drugs

Sylvain PERRUCHE

CEO

MED’INN’Pharma, France

11h20

Round Table I - Biotech Experts

- Descartes Auditorium

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

Titre de la track

- Plenary

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

12h00

Lunch at the Exhibition Hall

14h00

Parallel Workshops

- Descartes Auditorium

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Point-of-need analytics and process analytical technologies: 4 case studies

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

Titre de la track

- Pasteur Auditorium

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

15h30

Break

15h40

Biologics Developability - Session I

- Descartes Auditorium

Chairman

15h40

Canonical and complex antibody-based products developability

Alain BECK

Senior Director, Biologics CMC and Developability

Laboratoires Pierre Fabre, France

16h00

Developability assessment of next generation Biotherapeutics

Paul WASSMANN

Senior Principal Scientist

Novartis, Switzerland

16h20

A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization

Stefan ZIELONKA

Global Head of Antibody Discovery & Protein Engineering

Merck Healthcare KGaA, Germany

16h40

Title

Joelle EID

Field Application Scientist

GenSensor, France

16h50

Cell sampling ? A critical step to master your upstream bioprocess (USP) monitoring

Joelle EID

Field Application Scientist

GenSensor, France

Analytical Methods

- Pasteur Auditorium

Chairman

15h40

How to accelerate vaccine process development by digitalization and automation: definition of an optimized Workflow for Bioprocess and Analytic laboratories 

Stéphanie RICHARD

Analytical Immunology Process Support Unit Manager

Sanofi, France

10h30

Titre de la présentation

Loïc BENAIR

Senior Scientist Drug Substance Development

Sanofi, France

16h00

Leveraging single-cell transcriptomics to tailor insect cells for production of rAAV and influenza HA-VLPs

Antonio ROLDAO

Head of Vaccines Development Lab

iBET, Portugal

16h00

NGS based testing in biosafety, the experience from EFS

Sébastien RENOUF

Chief Pharmaceutical Officer

PathoQuest, France

16h00

Title

Pauline SOUETRE

Quality Control Manager

Etablissement Français du Sang (EFS), France

16h00

Multi-Attribute Analysis of mRNA by LC/MS

Arnaud DELOBEL

R&D and Innovation Director

Quality Assistance, Belgium

16h00

Application of the Ctech FlowVPX online PAT system for real-time monitoring of protein concentration and control of a TFF step

Bérengère FRANÇOIS

EU Bioanalytics Team Lead

Repligen, Europe

Alan DEDUYER

DSP Scientist Drug Substance Development

Sanofi, France

17h00

Coffee Break at the Exhibition Hall

17h40

Biologics Developability - Session II

- Descartes Auditorium

Chairman

17h40

Antibody and Antibody Drug Conjugates Developability

Matthieu CULIE

Head of Monoclonal antibodies industrial process development

GTP Bioways, France

10h30

Titre de la présentation

Yann DESFOUGERES

Project Manager & Designer

GTP Bioways, France

18h00

Why early mAb Sequence Optimization can Improve Developability and Reduce Costs

François COUTARD

Scientific Director, Head of Cell Line Development, Process & Product Design

Just Evotec Biologics, France

Christophe MARTIN

Senior Director Business Development Europe

Just Evotec Biologics, France

18h20

Title

Jochen UHLENKUKEN

Application Specialist Cell Density

Hamilton Bonaduz AG, Switzerland

18h30

In-line Cell Density Monitoring in Production – Principles and state-of-the-art Sensors

Jochen UHLENKUKEN

Application Specialist Cell Density

Hamilton Bonaduz AG, Switzerland

18h40

Innovative tools to monitor biological variability of bioprocesses

Philip PERROUD

Head of Process Development group

Naobios, France

Anne-Sophie GARY

Principal Scientist

GenSensor, France

18h50

Title

Michael SACHPEKIDIS

Senior Strategic Account Manager

Optimal Industrial Technologies, UK

Process modeling & Digital twins

- Pasteur Auditorium

Chairman

17h40

Future-Proofing with AI-Powered Bioprocess Development

Belma ALISPAHIC

Chief Scientific Officer

Analysis Mode, Finland

18h00

Genedata E2E Platform for Novel Modality R&D and Machine Learning

Maxime RANTZ

Scientific Consultant

Genedata, Switzerland

18h20

How can process modeling be used to accelerate development? A comparison of the mechanistic, hybrid, AI models

Eric CALVOSA

Senior Project Coordinator & Global Bioprocess Expert

Sanofi, France

19h00

Poster Session at the Exhibition Hall, Wine & Cheese

20h30

End of DAY 1

DAY 2

Thursday, 26 September 2024

08h00

Welcome Coffee

08h30

Sustainable Manufacturing

- Descartes Auditorium

Chairman

10h00

Titre de la présentation

Thibault RENAUD

Global Sustainability Supply Chain Leader

Cytiva, France

10h00

Titre de la présentation

Caroline CALMELS

Sustainability Market Manager

Saint-Gobain Life Science, France

10h30

Titre de la présentation

Clément GLACE

Life Sciences Manufacturing Solution Leader

Dassault Systèmes, France

10h30

Titre de la présentation

Adama OUATTARA

CEO and co-founder

Gencovery, France

Quality & Regulatory

- Pasteur Auditorium

Chairman

10h00

Specific CMC regulatory requirements to fill FIH in China, Taiwan and South Korea for a biological product

Carole LASSERRE

Regulatory Affairs Leader, CMC Pre-MA Expert

Laboratoires Pierre Fabre, France

10h30

Titre de la présentation

Hervé BROLY

ex-VP Biotech Process Development

Merck Serono, Switzerland

10h30

Expediting the Delivery of Innovative Biologics to the Clinic and Beyond

YuCai LI

Executive Director of CMC Management

WuXi Biologic, Sweden

09h40

Round Table II: Sustainable Manufacturing

- Descartes Auditorium

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

Round Table III: Quality & Regulatory

- Pasteur Auditorium

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h10

Coffee Break at the Exhibition Hall

10h50

Parallel Workshops

- Plenary

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

Titre de la track

- Plenary

Chairman

10h00

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

10h30

Titre de la présentation

Prénom NOM

Fonction

Entreprise, Pays

12h20

Lunch at the Exhibition Hall

14h00

Breakthrough Innovations in Bioproduction - Session II

- Descartes Auditorium

Chairman

14h00

Molecular optical spectroscopy as a PAT tool in USP bioprocessing

Igor CHOURPA

Professor, Director of EA 6295 Nanomedicines and Nanoprobes, Director of the Analytical Chemistry Laboratory

University of Tours, France

14h10

Design and development of chemically defined media supplemented with vegetable protein hydrolysates to enhance CHO cell growth and monoclonal antibody production

Fabien COMPEAU

Doctoral Researcher

Université Sorbonne Paris Nord, France

14h20

Production of scFv anti-STx2 using recombinant E. coli

José G.C. PRADELLA

Professor, Bioprocess Laboratory Coordinator

University of Paraíba Valley (Univap), Brazil

14h30

ModelForge – An initiative for optimal process operation with minimal effort

Gerardo BRAND RIHM

Co-Founder

ModelForge, Germany

14h40

The Solution Molecular Microscope gives you more thoughts about biopharmaceuticals

Hiroyuki KANDA

Global Product Leader

Rigaku Corporation, Japan

14h50

Title to be announced

Dorothy ZHANG

Vice President of Global Development

iGEM, France

15h00

Advancements and Perspectives in Bioproduction: Insights from Leading Experts of the Field

- Descartes Auditorium

Chairman

10h00

CIG A3P Biotherapy Processes - Update on Technical Guide: How to optimize the development and industrialization of your Biotherapy Product

Marie CECILLE

Head of CMC Leaders

Merck Life Science, France

10h30

Titre de la présentation

Géry VAN VYNCHT

Scientific Director

Quality Assistance, Belgium

10h30

How to select your CDMO? Insights from France Biotech’s biomanufacturing committee